Work

Longitudinal analysis of plasma ALK mutations during treatment with next-generation ALK inhibitors.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.9068

Authors: Ibiayi Dagogo-Jack, Marguerite Rooney, Rebecca Nagy, Subba Digumarthy, Emily Chin, Jennifer Ackil, Justin F. Gainor, Jessica Jiyeong Lin, Richard B. Lanman, Alice Tsang Shaw

Institutions: Massachusetts General Hospital, Guardant (United States), Harvard University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2954375805

Cites:

Cited by:

Related to: 10